• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

Recent Advances in the Application of 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester (CAS: 2223054-01-9) in Chemical Biology and Drug Discovery

The compound 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester (CAS: 2223054-01-9) has recently emerged as a promising building block in chemical biology and medicinal chemistry. This boronic acid derivative, characterized by its unique pyrimidine scaffold and cyclohexyl substituent, has garnered significant attention due to its versatile applications in drug discovery, particularly in the development of protease inhibitors and as a key intermediate in Suzuki-Miyaura cross-coupling reactions. Recent studies have highlighted its potential in targeting various disease pathways, making it a compound of considerable interest in pharmaceutical research.

One of the most notable applications of 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester is its role in the synthesis of novel kinase inhibitors. Kinases are critical targets in oncology, and the boronic acid moiety of this compound facilitates the formation of reversible covalent bonds with the active-site residues of kinases, enhancing both potency and selectivity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the design of selective inhibitors for Bruton's tyrosine kinase (BTK), a key player in B-cell malignancies. The study reported a significant improvement in binding affinity and pharmacokinetic properties compared to traditional non-covalent inhibitors.

In addition to its role in kinase inhibition, this compound has shown promise in the field of proteolysis-targeting chimeras (PROTACs). PROTACs are bifunctional molecules that recruit E3 ubiquitin ligases to degrade target proteins, and the boronic acid functionality of 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester has been exploited to target disease-relevant proteins for degradation. Recent work by researchers at the University of California, San Francisco, has utilized this compound to develop PROTACs targeting the androgen receptor (AR) in prostate cancer, achieving notable success in preclinical models.

The synthetic versatility of 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester has also been explored in the context of bioconjugation and chemical probe development. Its boronic acid group allows for efficient conjugation to biomolecules, enabling the creation of activity-based probes for studying enzyme function in complex biological systems. A 2022 study in ACS Chemical Biology detailed its use in profiling serine hydrolases, a diverse enzyme family implicated in numerous physiological and pathological processes. The study highlighted the compound's ability to provide high-resolution insights into enzyme activity and inhibition.

Despite its promising applications, challenges remain in the optimization of 4-Amino-2-(cyclohexyl)pyrimidine-5-boronic acid pinacol ester for clinical use. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further structural modifications and preclinical evaluations. However, the compound's unique chemical properties and demonstrated efficacy in early-stage research underscore its potential as a valuable tool in drug discovery. Future studies are expected to explore its applications in other therapeutic areas, including infectious diseases and neurodegenerative disorders, further expanding its utility in the pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)